Sun Pharma Advanced Research Share Price

₹ 176.46

-₹6.52 (-3.56%)
1D
Last updated 30 Oct, 2026, 15:58 IST
NSE: SPARC
|
Diversified

Sun Pharma Advanced Research Share Price Today

As of 30 Oct 2026, Sun Pharma Advanced Research share price is ₹176.46. The stock opened at ₹183.90, compared to its previous close of ₹182.98. During today's trading session, Sun Pharma Advanced Research share price moved in the range of ₹175.25 to ₹183.90, with an average price of ₹179.57 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.00 and a high of ₹289.00. On the performance front, Sun Pharma Advanced Research share price has increased by 23.36% over the last six months and is up 28.85% on a year-on-year basis.

Share price over the last 1 day fell from 182.90 to 176.50, ranging between 175.82 and 183.35.
₹175.25
3.56% down today
₹183.90
1D LOW
1D HIGH

Sun Pharma Advanced Research Stock Insights

Latest Earning
Op Profit TrendUp by 553.06% YoY
Latest Earning
Net Profit TrendUp by 553.48% YoY
Latest Earning
Revenue TrendUp by 2469.49% YoY
Stock Performance
OutperformingBeat Nifty by 35.88 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 6.56%
Shareholding Pattern
FIIFII decreased stake by 4.05%
Sun Pharma Advanced Research stock performance
Open₹183.90
High₹183.90
Low₹175.25
Prev. close₹182.98
Sun Pharma Advanced Research trading activity
Volume6,50,818
Average traded price₹178.33
Last traded time03:58:21 30 Oct
Last traded quantity2
Circuit
L
H
₹146.39
₹219.57
52-week
L
H
₹108.00
₹289.00
Mkt Cap Cr
5,924.14
P/E
3.75
P/B
4.44
ROA
72.98%
ROE
116.01%
ROCE
80.89%
Quick Ratio
2.47
EV/EBITDA
3.98

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
SPARC has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
SPARC appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
SPARC earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,990.7634.915.0611.19%13.74%17.33%2.3121.39
Divis Laboratories2,56,309.9187.6315.2914.6%15.32%19.56%3.557.62
Torrent Pharmaceuticals1,73,461.0682.719.454.7%11.42%11.37%0.7533.22
Laurus Labs1,21,300.09111.2522.899.47%16.77%16.14%0.6857.63
Zydus Lifesciences1,18,303.9525.764.368.57%18.59%17.35%0.9115.57
Dr. Reddy's Laboratories1,11,463.2140.492.884.79%7.21%8.58%1.3518.82
Cipla1,09,628.0438.413.16.6%8.18%10.8%2.520.82
Mankind Pharma1,02,583.8844.915.787.82%12.76%14.68%0.7424.99
Aurobindo Pharma95,225.0425.662.516.34%9.25%11.76%1.1512.11
Lupin90,132.4516.464.0714.47%23.76%24.88%1.429.64

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sun Pharma Advanced Research Company Background

ISIN
INE232I01014
Sector Market Cap
₹ 5,924.14 Cr

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.

Sun Pharma Advanced Research Financial Highlights

  • Revenue: Sun Pharma Advanced Research reported revenue of ₹1,890.12 crore in FY26 vs ₹73.56 crore in FY25. It showed an increase of 2,469.49% on a yearly basis.
  • Operating Profit: Sun Pharma Advanced Research reported an operating profit of ₹1,553.01 crore in FY26 vs ₹342.78 crore in FY25. It showed an increase of 553.06% on a year-on-year basis.
  • Net Profit: Sun Pharma Advanced Research reported a net profit of ₹1,553.20 crore in FY26 vs ₹342.51 crore in FY25. It showed an increase of 553.48% on a yearly basis.

Sun Pharma Advanced Research Quarterly Result Highlights

  • Sun Pharma Advanced Research reported revenue of ₹63.58 crore in Jun 2026, compared with ₹1,855.02 crore in Mar 2026, representing a decrease of 96.57% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported an operating loss of ₹20.67 crore in Jun 2026, compared with ₹1,760.96 crore in Mar 2026, representing a decrease of 101.17% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported a loss of ₹20.78 crore in Jun 2026, compared with ₹1,761.34 crore in Mar 2026, reflecting a decrease of 101.18% on a QoQ basis.
  • The earnings per share (EPS) of Sun Pharma Advanced Research stood at ₹47.86 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
65.67%
FII
3.75%
Other DII
0.01%
Retail and other
30.48%
Mutual funds
0.10%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20262.04%
May 20262.47%
Jun 20263.90%
Sep 20263.75%

Sun Pharma Advanced Research Investment Returns

1 day
-3.56%
1 week
+2.73%
1 month
-10.51%
1 year
+28.85%
3 years
-23.82%
5 years
-32.78%

Sun Pharma Advanced Research Share Price History

Sun Pharma Advanced Research share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
29 Oct 26
₹182.66 / ₹182.98
+0.18%
28 Oct 26
₹180.63 / ₹182.66
+1.91%
27 Oct 26
₹178.00 / ₹179.24
+0.47%
26 Oct 26
₹170.25 / ₹178.40
+3.86%
Show more

Sun Pharma Advanced Research Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.95₹1.79₹29.47₹10.88
Total Revenue₹1,890.12₹73.56₹105.01₹249.66
Total Expenses₹324.75₹416.34₹491.85₹472.24
Profit Before Tax₹1,553.01-₹342.78-₹386.83-₹222.58
Tax-₹0.19-₹0.27₹0.38₹0.00
Profit After Tax₹1,553.20-₹342.51-₹387.21-₹222.58
EPS - Basic₹47.86-₹10.55-₹11.93-₹7.82
EPS - Diluted₹47.86-₹10.55-₹11.93-₹7.82

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,553.01-₹342.78-₹386.83-₹222.58
Income before WC changes₹1,594.17-₹322.26-₹397.74-₹215.59
Change in Assets-₹1,850.30₹2.92-₹47.88₹5.40
Change in Liabilities-₹14.29-₹49.78₹20.54₹135.71
Change in WC-₹1,864.59-₹46.86-₹27.33₹141.11
Cash flow from Operations-₹238.78-₹360.29-₹429.19-₹69.12
Cash flow from Investing-₹23.50₹157.66₹391.53-₹548.28
Cash flow from Financing₹261.39₹199.26₹42.41₹616.76
Total Cash Flow-₹0.89-₹3.38₹4.74-₹0.64
Cash (Start of the year)₹1.96₹5.33₹0.58₹1.22
Cash (End of the year)₹1.16₹1.96₹5.33₹0.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹308.45₹309.34₹245.66₹375.16
Current Assets₹1,862.43₹26.20₹269.39₹454.96
Total Assets₹2,170.88₹335.53₹515.04₹830.13
Current Liabilities₹754.11₹374.24₹265.06₹178.95
Net Current Asset₹1,108.32-₹348.04₹4.33₹276.02
Non-Current Liabilities₹77.94₹178.24₹124.23₹138.41
Equity Capital₹1,338.83-₹216.95₹125.76₹512.78
Total Equity & Liabilities₹2,170.88₹335.53₹515.04₹830.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.83₹1.79₹29.47₹10.88
Total Revenue₹1,890.00₹73.56₹105.01₹249.66
Total Expenses₹325.50₹418.78₹493.12₹472.24
Profit Before Tax₹1,552.13-₹345.22-₹388.11-₹222.58
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹1,552.13-₹345.22-₹388.11-₹222.58
EPS - Basic₹47.83-₹10.64-₹11.96-₹7.82
EPS - Diluted₹47.83-₹10.64-₹11.96-₹7.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,552.13-₹345.22-₹388.11-₹222.58
Income before WC changes₹1,593.27-₹326.40-₹399.44-₹215.59
Change in Assets-₹1,850.28-₹19.94-₹25.34₹5.40
Change in Liabilities-₹13.52-₹26.86-₹0.54₹135.71
Change in WC-₹1,863.80-₹46.80-₹25.88₹141.11
Cash flow from Operations-₹238.89-₹362.41-₹429.43-₹69.12
Cash flow from Investing-₹23.51₹157.66₹391.11-₹548.28
Cash flow from Financing₹261.53₹200.88₹42.80₹616.76
Total Cash Flow-₹0.87-₹3.87₹4.48-₹0.64
Cash (Start of the year)₹1.19₹5.06₹0.58₹1.22
Cash (End of the year)₹0.32₹1.19₹5.06₹0.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹306.61₹304.02₹239.93₹375.16
Current Assets₹1,861.38₹25.26₹246.41₹454.96
Total Assets₹2,167.99₹329.28₹486.33₹830.13
Current Liabilities₹756.83₹373.72₹243.89₹178.95
Net Current Asset₹1,104.55-₹348.46₹2.52₹276.02
Non-Current Liabilities₹77.58₹176.17₹117.59₹138.41
Equity Capital₹1,333.59-₹220.62₹124.86₹512.78
Total Equity & Liabilities₹2,167.99₹329.28₹486.33₹830.13
* All values are in INR Crore
Sun Pharma Advanced Research market depth
Bid quantityBid priceAsk priceAsk quantity
00176.464
0000
0000
0000
0000
Total bid quantity0
Total ask quantity4
Sun Pharma Advanced Research technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
44.64
Neutral
ATR (14)
7.52
Neutral
STOCH(9,6)
65.12
Neutral
STOCH RSI (14)
90.41
Bearish
ADX(9)
16.24
Bullish
UO(9)
45.6
Neutral
ROC(12)
-1.01
Bearish
WillR(14)
-49.13
Neutral
Period
Simple value
Exponential vaue
5D
179.01
180.9
10D
180.94
181.9
20D
186.24
185.64
50D
193.59
193.35
100D
210.31
194.32
Volume trend — traded volume by day
30 Oct6L
29 Oct3L
28 Oct4L
27 Oct5L
26 Oct10L
23 Oct7L
Average6L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Sun Pharma Advanced Research
Diversified
Add Stock
Add Another

Mutual Funds Invested in Sun Pharma Advanced Research

Fund name
AUM
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
0.45%
Bandhan BSE Healthcare Index Fund
0.09%
Bandhan Nifty Total Market Index Fund
0.01%

Sun Pharma Advanced Research Returns Calculator

Top Gainers

LAURUSLABS Share Price
₹2405.50
+161.5 (+7.2%)
TRENT Share Price
₹3017.30
+155.6 (+5.44%)
ZYDUSLIFE Share Price
₹1245.50
+61.1 (+5.16%)
NAVINFLUOR Share Price
₹8680.00
+419.5 (+5.08%)
POONAWALLA Share Price
₹461.70
+20.2 (+4.58%)
See more

Top Losers

INTELLECT Share Price
₹504.55
-98.3 (-16.31%)
REDINGTON Share Price
₹326.95
-30.2 (-8.46%)
SUZLON Share Price
₹33.90
-2.89 (-7.86%)
COHANCE Share Price
₹444.30
-37.05 (-7.7%)
PNCINFRA Share Price
₹123.93
-10.05 (-7.5%)
See more

Sun Pharma Advanced Research Share Price FAQs

Please be aware that Sun Pharma Advanced Research stock prices are subject to continuous fluctuations due to various factors.